
Neurocrine Biosciences, Inc (NBIX) is ready for next Episode as it posted an annual sales of 2,355 M
On Tuesday, Neurocrine Biosciences, Inc (NASDAQ: NBIX) was 0.35% up from the session before settling in for the closing price of $124.56. A 52-week range